For example, S100A2 proteins enhance p53 transcriptional activity whereas S100A4 increases p53 apoptosis in models of adenocarcinoma, osteosarcoma, and oral carcinoma [12–14]. This evidence concerns the gene S100A4 and adenocarcinoma.